QS-B220 Explosives Trace Detector Approved for Air Cargo Security
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today that the U.S. Transportation Security Administration (TSA) has notified the Company that its Quantum Sniffer™ QS-B220 Explosives Trace Detector has successfully met the requirements for acceptance onto the Air Cargo Screening Technology List (ACSTL).
Implant Sciences' President and CEO Glenn D. Bolduc stated, "This announcement positions Implant Sciences to sell its products into the U.S. security marketplace, which accounts for approximately 43% of the world market. We are very proud to receive TSA approval and I want to congratulate our team and everyone who has worked so hard on this effort. Implant Sciences now becomes only the third trace detection manufacturer, and the sole American-owned company, to have achieved TSA approval. We've been preparing for this day and believe we have put the right team in place to execute on this significant opportunity."
Global GIS Market in the Military Sector 2014-2018
Implant Sciences' COO, Dr. William McGann, commented, "The QS-B220 introduces the next generation of explosives trace detection (ETD) technology. Our roadmap for the future includes new fundamental detection technologies that will improve sensitivity and reduce false alarm rates, and new sampling methodologies to extend explosives detection to a wider range of applications and environments."
Your company’s press release on ASDNews and to thousands of other journalists and editors? Use our ASDWire press release distribution service.
Source : Implant Sciences Corp.
Jun 24 - 25, 2015 - Prague, Czech Republic